Ameriprise
LONA

Ameriprise’s LeonaBio Inc LONA Stock Holding History

Ameriprise’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,627
Closed -$43.1K – 3932
2024
Q2 		$43.1K Sell
1,627
-200
-11% -$4.72K ﹤0.01% 3823
2024
Q1 		$50.1K Buy
+1,827
New +$58K ﹤0.01% 3813
2023
Q4 		– Sell
-1,530
Closed -$30.9K – 3901
2023
Q3 		$30.9K Hold
1,530
– – ﹤0.01% 3855
2023
Q2 		$45.1K Buy
1,530
+366
+31% +$10.4K ﹤0.01% 3868
2023
Q1 		$29.1K Sell
1,164
-2,291
-66% -$73.8K ﹤0.01% 3890
2022
Q4 		$110K Buy
3,455
+1
+0% +$32 ﹤0.01% 3802
2022
Q3 		$102K Buy
+3,454
New +$119K ﹤0.01% 3824
2022
Q2 		– Sell
-58,455
Closed -$7.89M – 3890
2022
Q1 		$7.89M Buy
58,455
+15,625
+36% +$1.65M ﹤0.01% 2093
2021
Q4 		$5.58M Sell
42,830
-1,382
-3% -$175K ﹤0.01% 2390
2021
Q3 		$4.15M Buy
+44,212
New +$4.5M ﹤0.01% 2517

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise's LONA Position: Q3 2024 in Review

Ameriprise sold out of LeonaBio Inc (LONA) in Q3 2024, closing a stake of 1,627 shares — an estimated $43.1K sold.

Ameriprise first reported a position in LONA in Q3 2021 and held it in 10 quarters. The position peaked at $7.89M in Q1 2022. 58 funds tracked by Wall St. Rank hold LONA as of Q3 2024.

  • Ameriprise reported no remaining LeonaBio Inc position as of Q3 2024 after selling out during the quarter.
  • Ameriprise sold 1,627 LeonaBio Inc shares in Q3 2024, an estimated $43.1K.
  • Ameriprise first reported a position in LeonaBio Inc in Q3 2021 and held it in 10 quarters.
  • Ameriprise's LeonaBio Inc position peaked at $7.89M in Q1 2022.
  • 58 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2024.

Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.